Health
Doctor and cancer survivor gears up to run 7 marathons on 7 continents in 7 days
A Wisconsin doctor is gearing up for the feat of a lifetime in order to spread awareness about the most pervasive cancer impacting young men.
Dr. T. Clark Gamblin, a surgeon in Milwaukee, spoke with Fox News Digital about his upcoming participation in the World Marathon Challenge. The competition involves running seven marathons on seven continents – seven days in a row.
The first marathon will take place in Antarctica on Jan. 31, 2025. From there, Gamblin and other participants will travel to Cape Town, South Africa; Perth, Australia; and Dubai, UAE.
THESE 17 CANCER TYPES ARE MORE COMMON IN GEN X AND MILLENNIALS, AS STUDY NOTES ‘ALARMING TREND’
From there, Gamblin will jet to Madrid, Spain, and Fortaleza, Brazil, before running a final race in Miami. He and his fellow marathon runners will have logged 183 miles over the course of a week.
Dr. T. Clark Gamblin, a cancer surgeon who battled testicular cancer, is running in the World Marathon Challenge, which involves running seven marathons on seven continents – seven days in a row. (Jan Gamblin, Ph.D.)
The fast-paced nature of the competition means that it won’t exactly be a relaxing vacation for the participants.
“Over the course of the seven days, we’ll spend about 60 hours on the plane,” Gamblin said. “So it’s running, and it’s plane, and it’s running, and then it’s plane.”
“If you’re prepared and you train correctly, it’s not some Herculean feat.”
While it may seem physically impossible for a human to run seven marathons in seven consecutive days, the World Marathon Challenge has taken runners across the world for nearly a decade. Gamblin began training for the race a year ago.
“It’s a physical challenge, there’s no doubt about it, but there are much more physically demanding things that people have done,” he said. “If you’re prepared and you train correctly, it’s not some Herculean feat.”
AFTER A BREAST CANCER DIAGNOSIS, HERE ARE 10 IMPORTANT THINGS YOU SHOULD DO, EXPERTS SAY
Gamblin has a whole team behind him. The World Marathon Challenge organization handles the logistics of all participants’ flights and hotels. A cancer surgeon, Gamblin also enlisted the help of a dietitian at his hospital to help him meet his protein and fluid goals.
He also has a physical trainer to help with injury prevention — but the person who has helped Gamblin the most, he said, is his wife.
Dr. T. Clark Gamblin spoke to Fox News Digital about his participation in the World Marathon Challenge. (Fox News Digital / Jan Gamblin, Ph.D.)
“She’s like my No. 1 cheerleader,” Gamblin said. “She’s not a big runner, but she’s a huge part of helping me get ready for this and preparing me for it.”
“But then right behind her would be my running coach, a dietitian and a physical therapist. So it does take a team to get ready for something like this.”
COVID-19 VIRUS COULD ATTACK CANCER CELLS AND SHRINK TUMORS, NEW STUDY SUGGESTS
Gamblin, who specializes in liver and bile duct cancer, became interested in running marathons as a medical school student. During the World Marathon Challenge, he will be running for the Testicular Cancer Awareness Foundation.
The cause is near to his heart, as Gamblin is a cancer survivor himself – he was diagnosed with testicular cancer in 2018 after noticing a lump.
Gamblin has been working with a dietitian and a physical trainer to prepare for the seven-day marathon challenge. (Jan Gamblin, Ph.D.)
“I thought it was probably nothing, but I was really diligent about it and checked it out very quickly and discovered it was testicular cancer,” he explained. “And testicular cancer is the No. 1 cancer that affects males aged 15 to 45.”
One out of every 250 men will develop testicular cancer in their lifetime, according to the Testicular Cancer Awareness Foundation.
“I went from being a cancer surgeon and giving all this advice, to having to take the advice I had been giving and apply it in my own life,” Gamblin noted.
“The most intriguing one is the Antarctica race … it’s going to be such a unique environment and climate to run in.”
After going through chemotherapy and two operations, he has now been cancer-free for four years.
Gamblin’s desire to spread awareness has fueled the long and arduous training he has gone through to prepare for the 168-hour-long feat.
Despite the challenges, he said he looks forward to the simple pleasures of the race, such as getting to know his fellow runners.
Gamblin will run a marathon on every continent, including Antarctica, starting in January. (Jan Gamblin, Ph.D.)
“It’ll be such a unique group of people, too,” he said. “I’m prepared to make some lifetime friendships and hear other people’s stories.”
Gamblin is documenting his marathon journey through his Instagram account, @tclarkgamblin. He’s most excited about running through Antarctica.
For more Lifestyle articles, visit www.foxnews.com/lifestyle
“So few people have run marathons there,” he said. “It’s going to be such a unique environment and climate to run in.”
In Miami, Gamblin will get to see his family at the finish line.
Gamblin said that he hopes his story encourages others to achieve their potential. (Jan Gamblin, Ph.D)
“I think that far too often, we don’t set our goals high enough in life,” the doctor said. “We don’t risk enough …This is a risk, it is a reach for me.”
The doctor said he aims to inspire other people to also set their sights higher than they normally would.
“Your body will in many cases do what the mind tells it to do,” Gamblin added.
“And so I think we can challenge ourselves and push ourselves far beyond … the limits that we set.”
NEWYou can now listen to Fox News articles!
A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period.
The personalized mRNA cancer therapy, called intismeran autogene, combined with the cancer immunotherapy drug KEYTRUDA (pembrolizumab), is a collaboration between Merck and Moderna.
The results from the phase 2b KEYNOTE-942 study were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on May 27.
CLICK HERE FOR MORE HEALTH STORIES
After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.
The researchers analyzed data from 157 patients with high-risk stage 3 and 4 melanoma whose cancer had been removed via surgery. The participants were split into two groups — one received the combo therapy and the other only received pembrolizumab, according to a press release.
The therapy was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone after a five-year follow-up. (iStock)
The findings revealed that the combination group saw benefits that were “sustained and durable over time.”
Intismeran autogene is designed using mutations identified in a patient’s own tumor, with the intention of teaching the immune system what the cancer looks like so that it can recognize and attack it.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
According to the researchers, intismeran is “well-tolerated” with a “manageable” safety profile.
The most commonly cited side effects of the personalized mRNA vaccine plus KEYTRUDA were fatigue, injection-site pain, chills, fever and headache. The researchers reported no new long-term safety concerns and no severe vaccine-related adverse events.
The combination therapy is currently being evaluated in a phase 3 study — the final confirmation stage.
Patients with late-stage melanoma have a “significant risk” of cancer recurrence, according to an expert. (iStock)
In a Merck press release from January, Kyle Holen, MD, Moderna’s senior vice president and head of development, oncology and therapeutics, noted that this data highlights the “potential of a prolonged benefit … in patients with resected high-risk melanoma.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“We continue to invest in our platform in oncology because of encouraging outcomes like these, which illustrate mRNA’s potential in cancer care,” he said.
Dr. Marjorie Green, senior vice president and head of oncology, global clinical development at Merck Research Laboratories, also commented that for many patients with stage 3 or 4 melanoma, there is a “significant risk of recurrence following surgery.”
Researchers confirmed that the combination therapy is currently being evaluated in a phase 3 study. (iStock)
“As such, demonstrating the longer-term potential of intismeran autogene and KEYTRUDA to reduce the risk of recurrence for certain patients with melanoma is a meaningful milestone,” she said.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The company cited encouraging five-year follow-up data and pointed to upcoming late-stage INTerpath trial results with Moderna in several hard-to-treat cancers.
NEWYou can now listen to Fox News articles!
An accidental lab discovery has opened the door to entirely new ways of preventing the flu.
While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells, SWNS reported.
By targeting the specific molecules the viruses rely on, scientists found that they could block them from entering new cells and halt their replication altogether.
5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS
Researchers say these “fundamental insights” into seasonal influenza highlight a clear path toward developing better preventive medications.
“The hope is that fundamental, curiosity-based research like this helps to pave the way for novel strategies to treat and prevent influenza infections,” principal investigator Dr. Emily Bruce, from the University of Vermont’s Larner College of Medicine, said in the SWNS report.
While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells. (iStock)
While several flu strains cause illness, H1N1 and H3N2 influenza A viruses are the most common. However, current flu tests cannot differentiate between them, and clinical treatments are identical for both.
Although vaccines and antivirals are available, Bruce noted a “dire” need for better medications to stop the virus from spreading cell to xxcell.
“You don’t get sick when a virus is in one cell,” he noted. “You get sick because a virus replicates itself and goes into many more cells.”
HOW LONG YOU’RE CONTAGIOUS WITH THE FLU — AND WHEN IT’S SAFE TO GO OUT
The study, which was published in The Journal of Virology, originally aimed to map how viral RNA segments are transported within cells to create new viral particles.
The team used H1N1 and H3N2 viruses isolated from the nasal passages of positive patients in 2022.
Clinical treatments remain identical for both primary strains of the flu virus. (iStock)
During the investigation, the team unexpectedly stumbled upon a cellular pathway that blocked the virus from entering lung cells, SWNS reported.
RESEARCHERS LOCKED FLU PATIENTS IN A HOTEL WITH HEALTHY ADULTS — NO ONE GOT SICK
The data revealed that when a specific human protein called Rab11B was depleted, H3N2 viruses failed to enter human lung cells. H1N1 viruses were completely unaffected.
Using reverse genetics, the team mapped this defect and uncovered a brand-new, H3N2-specific role for Rab11B during viral entry.
CLICK HERE FOR MORE HEALTH STORIES
This discovery challenged the scientific assumption that all flu viruses enter cells the same way.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Viruses are like pirates from different countries hijacking someone’s ship,” Bruce said. “Different viruses, like different types of pirates, use different methods to get onboard.”
This discovery challenged the scientific assumption that all flu viruses enter cells the same way. (iStock)
“We had previously thought that all flu viruses used the same way to get into a cell, but we discovered that this is not true,” she went on. “H1N1 and H3N2 need different proteins to get in, and if you get rid of the right protein, a specific virus can’t get in.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
While these findings identify a critical cellular pathway for viral entry, the study was conducted using isolated cells, the researchers acknowledged.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Further research is needed to determine whether blocking the protein is safe and effective within a live, complex human respiratory system.
Bruce and the team hope to conduct further research to determine whether this Rab11B-dependency is a fundamental property of H3N2, or if it’s a trait unique to currently circulating flu strains.
NEWYou can now listen to Fox News articles!
Eating processed meat like ham, sausage and bacon may be linked to a higher risk of certain types of cancer, according to new research.
While health organizations have already confirmed that processed meat can contribute to colon cancer, this study looked closer at cancers in the upper digestive tract, where the link has historically been less clear.
To understand these connections, researchers from the European Prospective Investigation into Cancer and Nutrition (EPIC), one of the world’s largest long-term nutrition and cancer cohorts, tracked the health and diets of 450,112 people across Europe for an average of 14 years.
FREQUENT HEARTBURN MAY BE A WARNING SIGN OF A MORE DANGEROUS CONDITION, DOCTOR SAYS
The study group included 131,426 men and 318,686 women, according to the study’s press release.
During the follow-up period, 876 people developed stomach cancer and 215 people developed esophageal adenocarcinoma, which is cancer of the tube connecting the mouth to the stomach.
For female participants, eating both processed meat and white meat was linked to an increased risk of developing the disease. (iStock)
Researchers tracked where the stomach cancers grew, separating them into the upper part of the stomach near the throat and the lower part of the stomach.
The researchers also sorted the tumors into two categories based on how the cancer cells appeared under a microscope: intestinal, which forms more organized structures, and diffuse, in which the cells are more scattered throughout the tissue.
BACTERIA IN YOUR MOUTH MAY TRAVEL TO THE GUT AND TRIGGER STOMACH CANCER, RESEARCH FINDS
After adjusting for other lifestyle factors, the researchers found that for every extra 30 grams of processed meat a person ate per day, their overall risk of stomach cancer went up by 9%. Eating that same extra 30 grams a day was also linked to a 13% higher risk of esophageal adenocarcinoma.
A standard single slice of regular deli-sliced ham or lunch meat averages around 28 grams, according to USDA data and nutritional tracking databases.
An extra 20 grams of white meat, such as chicken and turkey, was linked to a 12% higher risk of cancer in the main body of the stomach. (iStock)
An extra 20 grams of white meat, such as chicken or turkey, was linked to a 12% higher risk of cancer in the main body of the stomach, the researchers noted.
The study also revealed differences between men and women. For male participants, only processed meat showed a clear, statistically significant link to a higher risk of stomach cancer. For female participants, however, eating both processed meat and white meat was linked to an increased risk.
CLICK HERE FOR MORE HEALTH STORIES
These findings align with global health benchmarks, particularly those established by the World Health Organization’s International Agency for Research on Cancer.
The agency has long classified processed meat as a known human carcinogen, primarily due to its strong, well-documented links to colorectal cancer.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
However, health organizations have also consistently pointed to a potential, yet less definitive, relationship between these meats and cancers of the stomach.
Eating 30 grams of processed meat a day, or the equivalent to one slice of ham, was linked to a 13% higher risk of esophageal adenocarcinoma. (iStock)
Further scientific investigation is needed to confirm the findings and to account for other underlying risk factors, such as certain stomach infections, which could interact with dietary habits.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
A key limitation of the study is its reliance on self-reported diets, which can sometimes lead to inaccuracies in how participants recall their meat consumption over time, the researchers noted.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The findings were published in the International Journal of Cancer.
Fox News Digital reached out to the researchers requesting comment.
-
Los Angeles, Ca44 minutes agoOvernight military training brings loud flash bangs, simulated gunfire to quiet Pasadena neighborhood
-
Detroit, MI1 hour agoDetroit Lions add UDFA rookie WR during OTAs
-
San Francisco, CA1 hour agoHow to watch San Francisco Giants vs. Milwaukee Brewers
-
Dallas, TX1 hour ago3 different Cowboys 53-man roster projections pinpoint contested roster spots
-
Miami, FL1 hour agoJeff Hafley suggests Miami Dolphins entertain Malik Willis Tush Push
-
Boston, MA1 hour agoKaren Read sues the police agencies that investigated her Boston police boyfriend’s death
-
Denver, CO2 hours agoPedestrian dies after hit by car on southbound E-470, Aurora police say
-
Seattle, WA2 hours agoSeattle paying $2.6M to settle sexual harassment lawsuit filed by four female SPD officers – MyNorthwest.com
